Immune system response
A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice
Weight plateaus and some regain can occur if medication or lifestyle changes lapse, highlighting the importance of ongoing adherence to both aspects of treatment
(NEJM, 2023) the pivotal Retatrutide Phase 2 trial enrolled 338 participants across multiple dose cohorts (1mg, 4mg, 8mg, 12mg) over 48 weeks
The number of glaucoma cases associated with an actually elevated IOP varies significantly across glaucoma subtypes, and many glaucoma patients progress to blindness despite low IOPs and/or are refractory to IOP-lowering treatments (Dielemans et al., 1994
CJC-1295/Ipamorelin has been shown to stimulate protein synthesis, which leads to increase muscle growth, muscle fiber density, and thus, strength